Pinealon vs Semax
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Pinealon
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by the St. Petersburg Institute of Bioregulation and Gerontology — the same institution behind Epithalon and Cortexin. It is a short peptide bioregulator targeting the pineal gland and central nervous system. Research suggests it acts as an epigenetic regulator, penetrating cell nuclei to modulate gene expression in neurons, with reported effects on sleep quality, neuroprotection, circadian rhythm regulation, and age-related cognitive decline.
Full profileSemax
Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) — specifically the 4–7 fragment modified with a C-terminal Pro-Gly-Pro extension for stability. Developed in Russia in the 1980s and used clinically there for stroke recovery, cognitive enhancement, and neuroprotection, it is one of the most researched nootropic peptides with a decades-long safety record in Eastern European clinical practice. Its primary mechanism involves potent upregulation of BDNF (Brain-Derived Neurotrophic Factor).
Full profile| Pinealon | Semax | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | EDR, Glu-Asp-Arg, Pineal tripeptide | ACTH(4-7)PGP, Met-Glu-His-Phe-Pro-Gly-Pro |
| Evidence | Research-stage | Investigational (in trials) |
| Dosing range | 100mcg–300mcg mcg, Once daily (evening, given melatonin/sleep effects) | 200mcg–900mcg mcg, Once or twice daily (intranasal most common) |
| Administration | Subcutaneous injection, Intranasal, Oral (sublingual for better absorption) | Intranasal (preferred — high CNS bioavailability), Subcutaneous injection |
| Key side effects | Generally well-tolerated, Drowsiness if dosed during the day, Vivid dreams (common — melatonin pathway activation), Mild headache (uncommon) | Mild anxiety or restlessness at high doses, Nasal irritation (intranasal route), Increased energy / difficulty sleeping if dosed too late in the day, Mild appetite suppression |
| Cited sources | 2 references | 3 references |
Key differences
- Evidence level differs: Pinealon is research-stage, while Semax is investigational (in trials).
- Administration: Pinealon — Subcutaneous injection, Intranasal, Oral (sublingual for better absorption); Semax — Intranasal (preferred — high CNS bioavailability), Subcutaneous injection.
- Frequency: Pinealon is typically Once daily (evening, given melatonin/sleep effects); Semax is Once or twice daily (intranasal most common).
- Research depth: this profile cites 2 sources for Pinealon vs 3 for Semax.
How each works
Pinealon
Like other peptide bioregulators from the Khavinson group, Pinealon is proposed to work by penetrating the nuclear membrane and interacting directly with histones and promoter regions to regulate transcription. In vitro studies show Pinealon increases synthesis of serotonin and melatonin precursors in pinealocytes and upregulates antioxidant enzyme expression in neuronal cells. Animal studies demonstrate reduced neuronal apoptosis after hypoxic stress and improved performance in cognitive tasks. Clinical observations from Russian gerontology practice suggest benefits for insomnia, age-related cognitive decline, and neurological recovery.
Semax
Semax increases BDNF expression in the hippocampus and frontal cortex by 1.3–1.6x at research doses in rodent models. It also upregulates NGF (nerve growth factor) and modulates serotonin, dopamine, and NMDA receptor systems. Russian clinical data (not yet replicated in Western trials) suggests efficacy in ischemic stroke recovery, ADHD, glaucoma, and cognitive decline. The Pro-Gly-Pro C-terminal extension dramatically improves resistance to enzymatic degradation compared to native ACTH(4-7).
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.